NCT02470910View on ClinicalTrials.gov

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Prostate CancerAdenocarcinoma of the Prostate Stage IAdenocarcinoma of the Prostate Stage IIAdenocarcinoma of the Prostate Stage III
Interventions
DEVICE

Magnetic Resonance Imaging

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02470910 - Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning | Biotech Hunter | Biotech Hunter